We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,323 hedge funds and large institutions have $72.9B invested in Thermo Fisher Scientific in 2018 Q2 according to their latest regulatory filings, with 93 funds opening new positions, 512 increasing their positions, 492 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more first-time investments, than exits

New positions opened: 93 | Existing positions closed: 66

1% more funds holding

Funds holding: 1,3061,323 (+17)

4% more repeat investments, than reductions

Existing positions increased: 512 | Existing positions reduced: 492

0% more capital invested

Capital invested by funds: $72.6B → $72.9B (+$228M)

0.07% less ownership

Funds ownership: 87.63%87.56% (-0.07%)

6% less funds holding in top 10

Funds holding in top 10: 10599 (-6)

12% less call options, than puts

Call options by funds: $229M | Put options by funds: $260M

Holders
1,323
Holders Change
+17
Holders Change %
+1.3%
% of All Funds
30.28%
Holding in Top 10
99
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-5.71%
% of All Funds
2.27%
New
93
Increased
512
Reduced
492
Closed
66
Calls
$229M
Puts
$260M
Net Calls
-$30.8M
Net Calls Change
+$7M
Name Holding Trade Value Shares
Change
Change in
Stake
Commonwealth Equity Services
401
Commonwealth Equity Services
Massachusetts
$8.56M +$612K +2,882 +7%
SAM
402
Securian Asset Management
Minnesota
$8.54M +$27.6K +130 +0.3%
CHA
403
Cedar Hill Associates
Illinois
$8.53M -$1.22M -5,735 -12%
Dodge & Cox
404
Dodge & Cox
California
$8.51M -$144K -680 -2%
SC
405
Stralem & Co
New York
$8.45M -$5.31M -25,000 -38%
RSS
406
Rosenblum Silverman Sutton
California
$8.36M -$538K -2,533 -6%
TCOV
407
Trust Company of Vermont
Vermont
$8.25M +$425K +2,000 +5%
Mariner
408
Mariner
Kansas
$8.22M +$1.13M +5,317 +15%
MCM
409
Mitchell Capital Management
Kansas
$8.22M -$255K -1,201 -3%
CIC
410
Carnegie Investment Counsel
Ohio
$8.19M +$959K +4,520 +14%
BIM
411
Bridges Investment Management
Nebraska
$8.18M +$1.27M +5,967 +18%
HCMT
412
Highland Capital Management (Tennessee)
Tennessee
$8.16M +$14.2K +67 +0.2%
PAM
413
Panagora Asset Management
Massachusetts
$8.15M +$4.7M +22,145 +129%
UB
414
UMB Bank
Missouri
$8.15M -$149K -702 -2%
EAM
415
EULAV Asset Management
Florida
$8.14M
WT
416
Whittier Trust
California
$8.1M +$1.77M +8,362 +27%
BRCM
417
Bright Rock Capital Management
Massachusetts
$8.08M
FNBOO
418
First National Bank of Omaha
Nebraska
$8.06M +$111K +521 +1%
BC
419
Brinker Capital
Pennsylvania
$8.03M -$339K -1,597 -4%
PCA
420
Private Capital Advisors
Connecticut
$8.02M +$96.4K +454 +1%
SCM
421
Silvant Capital Management
Georgia
$8.02M +$104K +491 +1%
MKC
422
M. Kraus & Co
Vermont
$7.93M -$56K -264 -0.7%
MAM
423
Mastrapasqua Asset Management
Tennessee
$7.87M -$59.6K -281 -0.7%
SAM
424
Silvercrest Asset Management
New York
$7.81M +$147K +692 +2%
PBT
425
Pictet Bank & Trust
Bahamas
$7.77M -$811K -3,820 -9%

TMO Hedge Fund Activity: Q2 2018 in Review

1,323 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2018, worth a combined $72.9B — up 0.31% from $72.6B a quarter earlier.

Buyers outnumbered sellers: 93 funds opened new TMO positions and 66 closed out — a net gain of 27 holders — while 512 added to existing stakes and 492 trimmed.

The largest buyer was Viking Global Investors, adding an estimated $343M. The largest seller was Deutsche Bank, cutting an estimated $298M.

  • 1,323 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2018, up from 1,306 in Q1 2018.
  • Funds reported $72.9B of Thermo Fisher Scientific stock for Q2 2018, up 0.31% quarter-over-quarter.
  • 93 funds opened new Thermo Fisher Scientific positions in Q2 2018 and 66 closed out, a net change of +27 holders.
  • The largest Thermo Fisher Scientific buyer in Q2 2018 was Viking Global Investors, an estimated $343M added.
  • The largest Thermo Fisher Scientific seller in Q2 2018 was Deutsche Bank, an estimated $298M sold.

Based on aggregated 13F filings for Q2 2018.